Femarelle is a dietary supplement that is a mixture of DT56a (a tofu extract) and flaxseed powder, In 2008 an application was submitted to the European Food Safety Authority to market Femarelle with a health claim, namely that it can reduce the risk for osteoporosis and other bone disorders; the EFSA found that "the food/constituent for which the claim is made, i.e. Femarelle®, has not been sufficiently characterised" and that " a cause and effect relationship has not been established between the consumption of Femarelle® and increased BMD, increased bone formation, or decreased risk of osteoporosis or other bone disorders in post-menopausal women."<ref name=Poluzzi/>
Femarelle has been tested in small clinical trials. One studied its effect on the tissue lining the , another on relief of hot flashes in menopause, and another on the risk of causing blood clots, which is a risk of hormone replacement therapy. While results were promising, the studies were too small and too short in duration from which to draw conclusions.<ref name=Bedell2014review/>
|
